Related Experiment Video
Updated: Jul 13, 2026
![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)
05:15
Solid-phase Synthesis of [4.4] Spirocyclic Oximes
Published on: February 6, 2019
A concise total synthesis of melithiazole C
Julian Gebauer1, Stellios Arseniyadis, Janine Cossy
1Laboratoire de Chimie Organique, ESPCI, CNRS, 10 rue Vauquelin, F-75231 Paris Cedex 05, France.
Organic Letters
|July 20, 2007
Summary
Researchers developed a concise synthesis for the myxobacterial antibiotic melithiazole C. This efficient method utilizes a highly E-selective cross-metathesis as its core reaction.
Area of Science:
- Organic Chemistry
- Natural Product Synthesis
- Medicinal Chemistry
Background:
- Melithiazole C is a complex antibiotic produced by myxobacteria.
- The synthesis of complex natural products presents significant challenges.
- Developing efficient synthetic routes is crucial for accessing and studying such compounds.
Purpose of the Study:
- To devise a short and convergent synthetic strategy for melithiazole C.
- To establish a key E-selective cross-metathesis reaction for the synthesis.
Main Methods:
- Convergent synthesis approach.
- Olefin cross-metathesis reaction, specifically focusing on E-selectivity.
- Characterization of intermediates and final product.
Main Results:
- A short and convergent synthesis of melithiazole C was achieved.
- A highly E-selective cross-metathesis reaction was successfully employed as the key step.
- The synthesis demonstrates efficiency and practicality.
Conclusions:
- The developed synthetic route provides efficient access to melithiazole C.
- The key cross-metathesis step highlights advances in selective olefin coupling.
- This synthesis facilitates further investigation of melithiazole C's biological properties.
